Articles From: Covidien Receives U.S. FDA 510(k) Clearance for Reinforced Stapling Reload Technology to Covisint Demonstrates the Future of the Connected Owner Buying Experience at the LA Auto Show


2014/2/6
Covidien plc.
Sign-up for Covidien Receives U.S. FDA 510(k) Clearance for Reinforced Stapling Reload Technology investment picks
2014/1/22
Expanding its industry-leading vessel and tissue sealing portfolio, Covidien (NYSE:COV) received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LigaSure™ Maryland jaw open/laparoscopic sealer/divider. In addition, Covidien completed all European requirements to CE Mark the product.
Sign-up for Covidien Receives U.S. Food and Drug Administration Clearance for LigaSure™ Maryland Jaw investment picks
2013/10/14
Covidien (NYSE: COV), a leading global provider of healthcare products, has released positive final results from its DURABILITY II study and promising preliminary data from its DEFINITIVE AR trial at the Vascular Interventional Advances (VIVA) 2013 conference in Las Vegas, NV.
Sign-up for Covidien Releases Clinical Data Supporting Treatment and New Approach to Peripheral Arterial Disease investment picks
2014/1/24
Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2014 (October - December 2013). First-quarter net sales of $2.64 billion increased 3% from the $2.57 billion in the first quarter a year ago.
Sign-up for Covidien Reports First-Quarter Fiscal 2014 Results investment picks
Covidien plc (NYSE: COV) today reported results for the fourth quarter of fiscal 2013 (July - September 2013). Fourth-quarter net sales of $2.56 billion increased 2% from the $2.50 billion in the fourth quarter a year ago.
Sign-up for Covidien Reports Fourth-Quarter and Fiscal 2013 Results investment picks
Covidien plc (NYSE: COV) today reported results for the third quarter of fiscal 2013 (April - June 2013). Third-quarter net sales of $2.58 billion increased 3% from the $2.51 billion in the third quarter a year ago.
Sign-up for Covidien Reports Third-Quarter Results investment picks
2014/1/21
Covidien plc (NYSE: COV) today announced it will exit its OneShot™ Renal Denervation program.
Sign-up for Covidien to Exit OneShot™ Renal Denervation Program investment picks
Covidien (NYSE: COV) , a leading global provider of healthcare products, will host an investor meeting on Thursday, September 12, 2013, to update the investment community on the Company and its growth initiatives, strategic priorities and financial outlook.
Sign-up for Covidien to Host Investor Meeting on September 12, 2013 investment picks
2014/2/4
Covidien plc (NYSE: COV) will present at the 2014 Leerink Global Healthcare Conference in New York on Feb.
Sign-up for Covidien to Present at 2014 Leerink Global Healthcare Conference investment picks
2014/3/6
Covidien plc (NYSE: COV) will present at the Barclays Global Healthcare Conference 2014 in Miami on March 13.
Sign-up for Covidien to Present at Barclays Global Healthcare Conference 2014 investment picks
2013/11/14
Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Jefferies 2013 Global Healthcare Conference in London on November 21, 2013.
Sign-up for Covidien to Present at Jefferies 2013 Global Healthcare Conference investment picks
2014/2/24
Covidien plc (NYSE: COV) will present at the Raymond James 35th Annual Institutional Investors Conference in Orlando, Fla., on March 3.
Sign-up for Covidien to Present at Raymond James 35th Annual Institutional Investors Conference investment picks
2014/2/18
Covidien plc (NYSE: COV) will present at two upcoming investor conferences -- the Citi 2014 Global Healthcare Conference on Feb.
Sign-up for Covidien to Present at Upcoming Investor Conferences investment picks
Covidien (NYSE: COV), a leading global provider of healthcare products, announced today that it has entered into a definitive agreement with Integra LifeSciences Corporation to sell its Confluent Surgical product line.
Sign-up for Covidien to Sell Confluent Surgical Product Line to Integra LifeSciences investment picks
2013/10/28
By John Kell Covidien PLC (COV) has stuck a deal to sell the company's confluent surgical product line to Integra LifeSciences Holdings Corp.
Sign-up for Covidien to Sell Some Surgical Product Lines to Integra investment picks
Covidien plc (NYSE: COV), Lightstone Ventures and New Enterprise Associates (NEA) will jointly invest in a new company launched by The Foundry, a premier medical device incubator.
Sign-up for Covidien, Lightstone Ventures, New Enterprise Associates Announce Series A Investment in FIRE1 investment picks
2014/2/26
ORLANDO, Feb.
Sign-up for Covisint Achieves DirectTrust.org/EHNAC Accreditation investment picks
2014/2/7
DETROIT, Feb.
Sign-up for Covisint and EMA Webinar Helps Organizations Regain Control of SaaS and Cloud Investments investment picks
2014/3/13
DETROIT, March 13, 2014 (GLOBE NEWSWIRE) -- Covisint Corporation (Nasdaq:COVS) , provider of a leading cloud engagement platform, today announced preliminary results for its fourth quarter, fiscal year 2014.
Sign-up for Covisint Announces Preliminary Q4 FY '14 Results, Names Sam Inman Interim CEO investment picks
DETROIT, July 25, 2013 (GLOBE NEWSWIRE) -- Covisint, a Compuware (Nasdaq:CPWR) company, today announced that it has appointed Enrico Digirolamo as Chief Financial Officer.
Sign-up for Covisint Appoints Enrico Digirolamo as Chief Financial Officer investment picks
2013/10/21
DETROIT, Oct.
Sign-up for Covisint Corporation Announces Second Quarter Fiscal 2014 Earnings Release Date and Conference Call investment picks
Total revenue of $24.5 million up 19% year-over-year Subscription revenue of $16.2 million up 19% year-over-year Successfully completed initial public offering on September 26 for net proceeds of $68.4 million DETROIT, Oct.
Sign-up for Covisint Corporation Announces Second Quarter Fiscal 2014 Earnings Results investment picks
2014/1/13
DETROIT, Jan.
Sign-up for Covisint Corporation Announces Third Quarter Fiscal 2014 Earnings Release Date and Conference Call investment picks
2014/1/23
Subscription revenue of $17.6 million up 21% year-over-year Enterprise business unit revenue up 87% year-over-year 42 new customer agreements signed in Q3 Signs Cisco partnership agreement; focus on Internet of Everything DETROIT, Jan.
Sign-up for Covisint Corporation Announces Third Quarter Fiscal 2014 Earnings Results investment picks
2014/3/18
DETROIT, March 18, 2014 (GLOBE NEWSWIRE) -- Covisint Corporation (Nasdaq:COVS) , provider of the leading cloud engagement platform , today announced that its Chief Security Officer, David Miller, will highlight the core challenges of advanced persistent threats (APTs) facing today's businesses.
Sign-up for Covisint CSO to Detail How Oil & Gas Orgs Can Defend Against Advanced, Persistent Threats (APTs) investment picks
2013/11/18
LOS ANGELES, Nov.
Sign-up for Covisint Demonstrates the Future of the Connected Owner Buying Experience at the LA Auto Show investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Covidien Receives U.S. FDA 510(k) Clearance for Reinforced Stapling Reload Technology to Covisint Demonstrates the Future of the Connected Owner Buying Experience at the LA Auto Show
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity